At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
Dayspring Active Wearable Compression Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema
In Brief
A clinical study evaluating Dayspring Active Wearable Compression System for Lymphedema and 3 related conditions. Completed, enrolled 24 participants across 2 sites.
Detailed Summary
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Koya Dayspring Active Wearable Compression Technology for Treating Lower Extremity Lymphedema
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLymphedema, Lymphedema Lower Extremity, Chronic Venous Insufficiency, Secondary Lymphedema
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMay 2021
Enrollment StartJun 2021
Primary CompletionJun 2022
Study CompletionJul 2022
TodayJul 2026
First PostedMay 21, 2021
Enrollment StartJun 1, 2021
Primary CompletionJun 30, 2022
Study CompletionJul 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 5.1 years ago
Interventions
Dayspring Active Wearable Compression Systemdevice
Dayspring Active Wearable Compression System